EMC3

ER membrane protein complex subunit 3 · Q9P0I2 · EMC3 on Sugi Atlas →

0 patent compounds predicted against EMC3, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to EMC3 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes PHASE4UNKNOWN
Targeting Endoplasmic Reticulum Stress in Human Hypertension PHASE1/PHASE2RECRUITING
Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt) PHASE1/PHASE2RECRUITING
Phase I Study of Novel Estrogen Receptor(ER) a36 Modifier Icaritin in Advanced Breast Cancer Patients PHASE1UNKNOWN
Tamoxifen in Patients With Oesophageal Cancer PHASE1UNKNOWN
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
PBA Use for Treatment of ATF6-/- Patients EARLY_PHASE1SUSPENDED
Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer EARLY_PHASE1COMPLETED
Dynamics of Muscle Mitochondria in Type 2 Diabetes (DYNAMMO T2D) EARLY_PHASE1COMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
sCD163 in ALS Patients nanCOMPLETED
MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study) nanCOMPLETED
Hydroxychloroquin (HCQ) in chILD of Genetic Defect nanCOMPLETED
Nuclear Myosin VI - a Therapeutic Target in Breast Cancer nanUNKNOWN
Quantification of GADD34 Expression in RA nanCOMPLETED
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
The Role of DNA and RNA in NGS Analyses for Advaced Stage NSCLC Patients nanRECRUITING
Cerebellar Mutism Syndrome Study nanRECRUITING
Dynamics of Muscle Mitochondria in Type 2 Diabetes Exercise nanCOMPLETED
Muscle Tissue Bank for Muscular Dystrophy nanCOMPLETED
Establishment of Human Cellular Disease Models for Wilson Disease nanCOMPLETED
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis) nanCOMPLETED
Clinical Study of 68Ga-DOTA-BLP PET Imaging in Noninvasive Diagnosis of Malignant Tumors nanNOT_YET_RECRUITING
Investigation of Copy Number Variations and Genetic Variants in POI nanRECRUITING
BAP-EB as a Predictive Tool for Endometrial Receptivity and Pregnancy Outcome of IVF Treatment nanCOMPLETED
Autophagy Bladder Cancer nanUNKNOWN
Maternal Genes and Epimutations: Beckwith-Wiedemann Syndrome & Reproductive Risks nanRECRUITING
The Influence of Genetic Variations in ELAPOR1 or ELAPOR2 on Insulin Secretion and Glucose Regulation in Humans nanUNKNOWN
Genetic Analysis of Heart Channelopathies in Brazilian Patients and Their Relatives nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a EMC3 binder may also engage these)

ProteinNameSimilarity
Q3ZCB8 1.000 Q3ZCB8 →
Q5U2V8 1.000 Q5U2V8 →
Q99KI3 1.000 Q99KI3 →
Q5R7C1 1.000 Q5R7C1 →
Q7SXW4 1.000 Q7SXW4 →
Q5R9K4 0.951 Q5R9K4 →
Q42450 0.950 Q42450 →
Q6INE8 0.950 Q6INE8 →
Q99KU0 0.950 Q99KU0 →
A9JRA0 0.949 A9JRA0 →
O98997 0.949 O98997 →
Q9ZT00 0.949 Q9ZT00 →
Q68EQ9 0.948 Q68EQ9 →
Q40281 0.948 Q40281 →
Q0VCK9 0.948 Q0VCK9 →
A2R0Z5 0.948 A2R0Z5 →
Q40460 0.947 Q40460 →
Q01587 0.947 Q01587 →
Q7ZUA6 0.947 Q7ZUA6 →
Q3ZCK1 0.947 Q3ZCK1 →
VMP1 Vacuole membrane protein 1 0.947 landscape →
Q28CY9 0.947 Q28CY9 →
EIF3L Eukaryotic translation initiation factor 3 subunit L 0.947 landscape →
Q40565 0.946 Q40565 →
Q2U834 0.946 Q2U834 →
P93431 0.946 P93431 →
Q6DD44 0.946 Q6DD44 →
Q8QZY1 0.946 Q8QZY1 →
Q6P878 0.946 Q6P878 →
Q5R6E0 0.946 Q5R6E0 →